Get started
Author

Flavia Melotti

Papillary carcinoma of the thyroid: low expression of NCAM (CD56) is associated with downregulation of VEGF‐D production by tumour cells
2007 · S Scarpino, A Di Napoli, et al. · The Journal of Pathology · 64
Pathological response after neoadjuvant bevacizumab- or cetuximab-based chemotherapy in resected colorectal cancer liver metastases
2015 · Filippo Pietrantonio, Vincenzo Mazzaferro, et al. · Medical Oncology · 28
A modified vimentin histological score helps recognize pulmonary sarcomatoid carcinoma in small biopsy samples.
2012 · Giuseppe Pelosi, Flavia Melotti, et al. · PubMed · 28
PDF
Gastroblastoma in Adulthood—A Rarity among Rare Cancers—A Case Report and Review of the Literature
2019 · Giovanni Centonze, Alessandro Mangogna, et al. · Case Reports in Pathology · 26
PDF
A subset of genetic susceptibility variants for colorectal cancer also has prognostic value
2015 · S Noci, M Dugo, et al. · The Pharmacogenomics Journal · 25
Hamartoma of mature cardiac myocytes in adults and young: Case report and literature review
2012 · Giuseppe Maria Raffa, Pietro Giorgio Malvindi, et al. · International Journal of Cardiology · 17
Gene expression profiling reveals GC and CEACAM1 as new tools in the diagnosis of lung carcinoids
2014 · F Toffalorio, E Belloni, et al. · British Journal of Cancer · 16
PDF
TP53 Mutations in Advanced Colorectal Cancer: The Dark Side of the Moon
2014 · Filippo Pietrantonio, Pamela Biondani, et al. · Oncology · 13
Protein drug target activation homogeneity in the face of intra-tumor heterogeneity: implications for precision medicine
2016 · Erika Maria Parasido, Alessandra Silvestri, et al. · Oncotarget · 9
PDF
Sirolimus and regression of Kaposi's sarcoma in immunosuppressed transplant patient
2008 · G Pranteda, G Feliziani, et al. · Journal of the European Academy of Dermatology and Venereology · 9
Unresectable stage III non-small cell lung cancer: could durvalumab be safe and effective in real-life clinical scenarios? Results of a single-center experience
2023 · Paolo Borghetti, Giulia Volpi, et al. · Frontiers in Oncology · 8
Role of BAX for outcome prediction in gastrointestinal malignancies
2013 · Filippo Pietrantonio, Pamela Biondani, et al. · Medical Oncology · 8
Succinate Dehydrogenase B Subunit Immunohistochemical Expression Predicts Aggressiveness in Well Differentiated Neuroendocrine Tumors of the Ileum
2012 · Massimo Milione, Sara Pusceddu, et al. · Cancers · 7
PDF
Immunoglobulin light chain transcript detection by ultrasensitive RNA in situ hybridization for B-cell lymphoma diagnosis
2023 · Luisa Lorenzi, Silvia Lonardi, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 5
Actinic Reticulosis with clonal TCR (T-cell receptor) gene rearrangement.
2008 · Flavia Melotti, Elena Mari, et al. · PubMed · 3
High pathologic response rate of hepatic colorectal cancer metastases (HCRM) following neoadjuvant bevacizumab (Bev)-based treatment (tx).
2013 · Filippo Pietrantonio, Jorgelina Clara Coppa, et al. · Journal of Clinical Oncology · 2
Lack of Bax expression is associated with irinotecan-based treatment activity in advanced colorectal cancer patients
2012 · F. Pietrantonio, P. Biondani, et al. · Clinical & Translational Oncology · 2
Correction to: Immunoglobulin light chain transcript detection by ultrasensitive RNA in situ hybridization for B-cell lymphoma diagnosis
2023 · Luisa Lorenzi, Silvia Lonardi, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
PDF
Real Time Quantitative PCR Publications
2014 · Gabriele Bucci, Laura Tizzoni, et al.
Contents Vol. 86, 2014
2014 · Suzanne R. Hayman, Juan C. Calle, et al. · Oncology
PDF
Pathologic response, KRAS status, and bevacizumab: The Bermuda triangle for outcome prediction after hepatic colorectal cancer metastases (HCRM) resection.
2013 · Giuseppe Fanetti, Pamela Biondani, et al. · Journal of Clinical Oncology
Prognostic Role of ERCC1, Bax and TP53 in Advanced Colorectal Cancer (CRC) PTS Randomly Assigned to First-Line UFT/Leucovorin (LV) Plus Irinotecan (Tegafiri) Versus UFT/LV Plus Oxaliplatin (Tegafox)
2012 · F. Pietrantonio, P. Biondani, et al. · Annals of Oncology
PDF
Works count: 22
Citation count: 270
H-index: 9
I10-index: 8
Year
Topic
Type